{"data":{"id":"us-mt/50-12-104","jurisdiction":"us-mt","citation":"50-12-104","heading":"Patient requirements.","body":"A patient is eligible for an experimental treatment if the patient has:\n(1) evaluated other treatment options currently approved by the United States food and drug administration;\n(2) received a recommendation from the patient's treating health care provider for an experimental treatment;\n(3) given informed consent for the use of the experimental treatment; and\n(4) received documentation from the treating health care provider that the patient meets the requirements of this section.","path":["TITLE 50. HEALTH AND SAFETY","CHAPTER 12. TREATMENTS FOR CHRONIC OR TERMINAL ILLNESS","Part 1. Right to Try Act"],"source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0120/part_0010/section_0040/0500-0120-0010-0040.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:56:13Z","sha256":"15c08ef78ee1a4dad3f3747cb30ae87b76b829c97e1b4483de80cdfbf26e7a44","source_id":"us-mt","stale":false,"prev":"us-mt/50-12-103","next":"us-mt/50-12-105"},"notice":"GroundRules: Original legal text. Not legal advice."}